2013 Banff Criteria for Chronic Active Antibody-Mediated Rejection: Assessment in a Real-Life Setting

American Journal of Transplantation

Volumn 16, Issue 5, 2016, Pages 1516-1525

  De Serres, S A ^a   Noel R ^a   Cote I ^a   Lapointe, I ^a   Wagner, E ^a   Riopel, J ^a   Latulippe, E ^a   Agharazii, M ^a   Houde, I ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HLA ANTIBODY; ALLOANTIBODY; COMPLEMENT COMPONENT C4B; HLA ANTIGEN;

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CAPILLARITIS; CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION; CHRONIC GRAFT REJECTION; COHORT ANALYSIS; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENDOTHELIUM; FEMALE; FOLLOW UP; GLOMERULITIS; GRAFT FAILURE; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ALLOTRANSPLANTATION; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR;

COMPLEMENT C4B; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84954460944     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13624     Document Type: Article

References (36)

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al., Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341 (23): 1725-1730.
2. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK,. Renal transplantation in elderly patients older than 70 years of age: Results from the Scientific Registry of Transplant Recipients. Transplantation 2007; 83 (8): 1069-1074.
3. Sayegh MH, Carpenter CB,. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 2004; 351 (26): 2761-2766.
4. Matas AJ, Smith JM, Skeans MA, et al., OPTN/SRTR 2012 annual data report: Kidney. Am J Transplant 2014; 14 (Suppl 1): 11-44.
5. 2014 CORR Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012. 2014. Available from: https://securecihica/estore/productFamilyhtm?locale=en&pf=PFC2481.
6. El-Zoghby ZM, Stegall MD, Lager DJ, et al., Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9 (3): 527-535.
7. Sellares J, de Freitas DG, Mengel M, et al., Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12 (2): 388-399.
8. Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M,. Diagnosis and management of antibody-mediated rejection: Current status and novel approaches. Am J Transplant 2014; 14 (2): 255-271.
9. Farkash EA, Colvin RB,. Diagnostic challenges in chronic antibody-mediated rejection. Nat Rev Nephrol 2012; 8 (5): 255-257.
10. Haas M, Sis B, Racusen LC, et al., Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14 (2): 272-283.
11. Einecke G, Sis B, Reeve J, et al., Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9 (11): 2520-2531.
12. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9 (10): 2312-2323.
13. Loupy A, Suberbielle-Boissel C, Hill GS, et al., Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9 (11): 2561-2570.
14. Papadimitriou JC, Drachenberg CB, Ramos E, et al., Antibody-mediated allograft rejection: Morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation 2013; 95 (1): 128-136.
15. Hara S,. Banff 2013 update: Pearls and pitfalls in transplant renal pathology. Nephrology 2015; 20 (Suppl 2): 2-8.
16. Sis B, Jhangri GS, Riopel J, et al., A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12 (5): 1168-1179.
17. Djamali A, Muth BL, Ellis TM, et al., Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients. Kidney Int 2013; 83 (6): 1185-1192.
18. Loupy A, Hill GS, Suberbielle C, et al., Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11 (1): 56-65.
19. Gaston RS, Cecka JM, Kasiske BL, et al., Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90 (1): 68-74.
20. Kedainis RL, Koch MJ, Brennan DC, Liapis H,. Focal C4d- in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival. Am J Transplant 2009; 9 (4): 812-819.
21. Haas M, Mirocha J,. Early ultrastructural changes in renal allografts: Correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 2011; 11 (10): 2123-2131.
22. Ivanyi B, Fahmy H, Brown H, Szenohradszky P, Halloran PF, Solez K,. Peritubular capillaries in chronic renal allograft rejection: A quantitative ultrastructural study. Hum Pathol 2000; 31 (9): 1129-1138.
23. Randhawa P,. T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: Diagnostic challenges and clinical significance. Curr Opin Organ Transpl 2015; 20 (3): 325-332.
24. Rothman KJ, Greenland S, Lash TL,. Modern epidemiology. III ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
25. Mengel M, Sis B, Haas M, et al., Banff 2011 Meeting report: New concepts in antibody-mediated rejection. Am J Transplant 2012; 12 (3): 563-570.
26. Mengel M, Bogers J, Bosmans JL, et al., Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005; 5 (5): 1050-1056.
27. Magil AB, Tinckam KJ,. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant 2006; 21 (5): 1382-1388.
28. Solez K, Colvin RB, Racusen LC, et al., Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8 (4): 753-760.
29. Sapir-Pichhadze R, Curran SP, John R, et al., A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. Kidney Int 2015; 87 (1): 182-194.
30. Mengel M, Chan S, Climenhaga J, et al., Banff initiative for quality assurance in transplantation (BIFQUIT): Reproducibility of C4d immunohistochemistry in kidney allografts. Am J Transplant 2013; 13 (5): 1235-1245.
31. Hidalgo LG, Campbell PM, Sis B, et al., De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9 (11): 2532-2541.
32. Kahwaji J, Najjar R, Kancherla D, et al., Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab. Clin Transplant 2014; 28 (5): 546-553.
33. John R, Konvalinka A, Tobar A, Kim SJ, Reich HN, Herzenberg AM,. Determinants of long-term graft outcome in transplant glomerulopathy. Transplantation 2010; 90 (7): 757-764.
34. Kozakowski N, Herkner H, Bohmig GA, et al., The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss. Kidney Int 2015; 88 (2): 332-340.
35. Gibson IW, Gwinner W, Brocker V, et al., Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8 (4): 819-825.
36. Loupy A, Vernerey D, Tinel C, et al., Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. J Am Soc Nephrol 2015; 26 (7): 1721-1731.